"The Challenge of Diagnosing and Treating a Common Hormonal Condition in Women"
Polycystic ovary syndrome (PCOS) affects an estimated 5 million women in the U.S., causing a range of debilitating symptoms. Despite its prevalence, PCOS is poorly understood, and there is no FDA-approved medication specifically for the condition. Women with PCOS often rely on off-label prescriptions and struggle to navigate insurance coverage. Insufficient funding for research has limited progress in developing effective treatments, but there are some promising signs with small drug companies studying possible PCOS treatments. The rise of online communities has provided women with PCOS a platform to share experiences and seek support, offering hope for better management of the condition.
